Vstm stocktwits.

Get the LIVE share price of Verastem Inc(VSTM) and stock performance in one place to strengthen your trading strategy in US stocks. Now Start Investing in Verastem Inc on GrowwFind the latest Earnings Report Date for Verastem, Inc. Common Stock (VSTM) at Nasdaq.com.395.72%. Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -13.13M. -104.56%. Get the latest Verastem Inc (VSTM) real ...VSTM (ZB_9894335.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock VSTM | Nasdaq: | Nasdaq

BOSTON, January 24, 2023--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announces positive interim data from ...

Their AKBA share price forecasts range from $3.75 to $3.75. On average, they expect the company's share price to reach $3.75 in the next year. This suggests a possible upside of 253.8% from the stock's current price. View analysts price targets for AKBA or view top-rated stocks among Wall Street analysts.Discover historical prices for VSTM stock on Yahoo Finance. View daily, weekly or monthly formats back to when Verastem, Inc. stock was issued.

116.99. 98.49. If you are buying or selling stocks and funds listed abroad, you could be hit with extra cost for your cross border money transfer. Use Wise money transfer to avoid hidden currency exchange markup or open a Wise account to conveniently manage your money in up to 40 currencies. Learn more about Wise.Fundamentals. Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered ...The average price recommended by analysts for Verastem Inc. (VSTM) i. Moreover, the 36-month beta value for VSTM is 0.70. Analysts have varying opinions on the stock, with 7 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.” The average price recommended by analysts for Verastem Inc. (VSTM) i$VSTM (VSTM) Verastem stock attempting to move higher off 7.69 double support area w/ bullish stats, analysisVerastem (VSTM) Message Board | InvestorsHub 4,274.51 0.02% ) 14,201.60 ( 0.00% ) Dow Jones 33,550.27 ( -0.20% ) Brent Oil 94.86 ( 0.58% ) Home Boards US Listed …

Verastem (VSTM) Message Board | InvestorsHub 4,274.51 0.02% ) 14,201.60 ( 0.00% ) Dow Jones 33,550.27 ( -0.20% ) Brent Oil 94.86 ( 0.58% ) Home Boards US Listed …

Verastem Oncology Enters Discovery and Development Collaboration with GenFleet Therapeutics to Advance New Programs Targeting RAS Pathway-Driven Cancers. Find the latest Verastem, Inc. (VSTM) stock quote, history, news and other vital information to help you with your stock trading and investing.

As of June 2, 2023, the average one-year price target for Verastem is 39.78. The forecasts range from a low of 24.24 to a high of $63.00. The average price target represents an increase of 393.85% ...Complete Verastem Inc. stock information by Barron's. View real-time VSTM stock price and news, along with industry-best analysis.What's Happening With VSTM Stock Today? Verastem Inc (VSTM) stock is trading at $1.17 as of 9:57 AM on Tuesday, May 30, a rise of $0.16, or 15.84% from the previous closing price of $1.01. The stock has traded between $1.00 and $1.20 so far today. Volume today is 3,124,850 compared to average volume of 3,429,309.Complete Verastem Inc. stock information by Barron's. View real-time VSTM stock price and news, along with industry-best analysis.VSTM on Twitter. Verastem, Inc., a biopharmaceutical company, focuses on discovering and developing proprietary small molecule drugs targeting cancer stem cells (CSCs) with companion diagnostics. Its programs target the Focal Adhesion Kinase (FAK) and the PI3K/mTOR signaling pathways. The company's lead FAK inhibitor, VS-6063, is in Phase I/Ib ...A high-level overview of Amgen Inc. (AMGN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Verastem Oncology (NASDAQ:VSTM) COO and President Dan Paterson has been promoted to President and Chief Executive Officer role, effective August 1, 2023.Brian Stuglik will retire from the CEO role ...Short selling VSTM is an investing strategy that aims to generate trading profit from Verastem as its price is falling. VSTM shares are trading up $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender.V: D: 20231005 22:59:39. Verastem (VSTM) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...Based on targets from 5 analysts, the average taret price for VSTM is projected at USD 26.63 over the next 12 months. This means that VSTM's stock price may go up by +168.94% over the next 12 months. Heading 1 Verastem Oncology has received little in the way of analyst coverage over the past year. On May 24th, BTIG upgraded VSTM to a Buy from a Neutral rating and place a $8 price target on the shares. A ...View VSTM Interactive Graph, technical analysis, real-time price quote, changing the time intervals, etc. Top Stocks. Top Analyst Stocks Top Smart Score Stocks Top Insiders Stocks. Popular. Stock Screener Top Online Growth Stocks Trending Stocks Penny Stock Screener Newsletter Center.

Year 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 - 2011; Net IncomeGet instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20! Get market updates, educational videos, webinars, and stock analysis. Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content.

The 7 analysts offering 12-month price forecasts for Verastem Inc have a median target of 34.00, with a high estimate of 39.00 and a low estimate of 17.50. The median estimate represents a +347.37 ...Join this channel to get access to perks:https://www.youtube.com/channel/UCQvSqObd4nnhUWRm7fkRiRA/join-----...90.98%. Trailing 12-Months. The Verastem stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human ...Verastem Oncology has received little in the way of analyst coverage over the past year. On May 24th, BTIG upgraded VSTM to a Buy from a Neutral rating and place a $8 price target on the shares. A ...BOSTON, June 16, 2023--Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the pricing of an underwritten public offering of 7,181,409 shares of its common stock at a price to the public of $9.75 per share and, in lieu of common stock to certain investors ...Verastem (VSTM) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one ...By Investing.com. • May 09, 2023. Investing.com - Verastem (NASDAQ: VSTM) reported first quarter EPS of $-0.090, worse than the analyst estimate of $-0.080. Revenue for the quarter came in at $0 ...

It is currently -37.42% from its 52-week high and 173.46% from its 52-week low. How much is Verastem stock worth today? ( NASDAQ: VSTM) Verastem currently has 25,250,711 outstanding shares. With Verastem stock trading at $9.50 per share, the total value of Verastem stock (market capitalization) is $239.88M.

On January 27, 2023 Verastem Oncology closed on the initial tranche of 1.2 million shares of its Series B Convertible Preferred Stock (the "Preferred Stock") with gross proceeds of $30 million. The following information was filed by Verastem, Inc. (VSTM) on Thursday, February 2, 2023 as an 8K 2.02 statement, which is an earnings press ...

Verastem (VSTM) stock is jumping after the company reported a narrower-than-expected loss for the 2015 fourth quarter. VSTM. OPINION. Mar 2, 2016 6:57 AM EST.Verastem Oncology Announces Pricing of $85.0 Million Public Offering of Common Stock and Pre-Funded Warrants. BOSTON-- (BUSINESS WIRE)--Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the pricing of an underwritten pu...Verastem Oncology Announces Pricing of $85.0 Million Public Offering of Common Stock and Pre-Funded Warrants. BOSTON-- (BUSINESS WIRE)--Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the pricing of an underwritten pu...Verastem, Inc. (VSTM) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 8.06 +0.46 (+6.05%) At close: 04:00PM EDTInvestorPlace - Stock Market News, Stock Advice & Trading Tips Verastem (NASDAQ:VSTM) stock is on the rise Monday morning following an announc...Sign in with Google Sign in with Facebook Sign in with Apple or. Remember MeVSTM stock was up 6.2% as of Monday morning. There's more recent stock market news worth checking out below! We've got all the latest stock market coverage that traders need to know about.Discover Verastem Inc (VSTM) market and community sentiment, movement in message volume, participation score and buzz level in the Stocktwits communityVSTM is UP 105% since the begininning of the year. VSTM is DOWN -1% BELOW 20 day SMA. VSTM is UP 37% ABOVE 200 day SMA. FINANCIALS. PROFITABLE: NO EPS: $-1.37. EARNINGS MOMENTUM: NO 0.59% DECREASE IN QTRLY EARNINGS. P/E RATIO IS: N/A INCOME TO DEBT RATIO: 0.00. REVENUE IS: N/A DEBT IS: 50KMizuho Securities analyst Mara Goldstein maintained a Hold rating on Verastem (VSTM - Research Report) today and set a price target of $24.00.The company's shares closed yesterday at $1.02 ...

View the latest Verastem Inc. (VSTM) stock price, news, historical charts, analyst ratings and financial information from WSJ.Verastem Presents Avutometinib and Defactinib Combination Program Updates at the 5th Annual RAS-Targeted Drug Development Summit. BOSTON, September 28, 2023--Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the presentation of scientific background and clinical trial updates on the avutometinib and ...VSTM Signals & Forecast. A buy signal was issued from a pivot bottom point on Wednesday, October 04, 2023, and so far it has risen 8.92%.Further rise is indicated until a new top pivot has been found. Verastem has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation.Verastem Inc (VSTM) stock has risen 3.28% while the S&P 500 has fallen -0.48% as of 1:25 PM on Wednesday, Jan 25. VSTM has risen $0.02 from the previous closing price of $0.61 on volume of 1,459,361 shares. Over the past year the S&P 500 is lower by -9.35% while VSTM has fallen -59.09%. VSTM lost -$0.40 per share in the over the last 12 months.Instagram:https://instagram. cspire outageeldoark classifieds gunsicoworkergasko's nursery VSTM.US volatility (beta: 0.59) Avg. volatility (beta: 1.00) Low High. Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Verastem's is 0.5934. This would suggest that Verastem's shares are less volatile than average (for this exchange).PLRX. Pliant Therapeutics. RCAT. Red Cat. ICPT. Intercept. Breaking News - The Fly. The Fly team scours all sources of company news, from mainstream to cutting edge,then filters out the noise to deliver shortform stories consisting of only market moving content. florian sukaj teethshooting in naperville il today Verastem Oncology, (VSTM) has priced public offering of 7,181,409 shares of its common stock at of $9.75 per share and pre-funded warrants to purchase up to 1,538,591 shares of its...Find the latest dividend history for Verastem, Inc. Common Stock (VSTM) at Nasdaq.com. elmo's world up and down quiz The Quality+Value Score was analysed by an independent firm and they found that an investing strategy based on the model outperformed both the Russell 2000 and the S&P over time. In one test over the period of 1992 to 2013, the theoretical CAGR of the Quality+Value score was 20.73% vs. the Russell 2000 CAGR of 10.33%.Verastem (VSTM) stock is jumping after the company reported a narrower-than-expected loss for the 2015 fourth quarter. VSTM. OPINION. Mar 2, 2016 6:57 AM EST.A look at the shareholders of Verastem, Inc. (NASDAQ:VSTM) can tell us which group is most powerful.Institutions often own shares in more established companies, while it's not unusual to see ...